Mylan Laboratories Inc. said its Mylan Pharmaceuticals Inc. unit acquired the exclusive right to a generic formulation of Seldane-D, an allergy medication, from a unit of Andrx Corp., a private biotechnology company based in Fort Lauderdale, Fla.
Terms weren't disclosed.
Mylan said it now has the exclusive right to make, use, promote and sell a generic sustained-release formulation of Seldane, or terfenadine/pseudoephedrine hydrochloride, in the U.S., Puerto Rico and Canada.
Mylan, a generic-drug company, will develop the product jointly with Andrx's Anda SR Pharmaceuticals Inc.
Seldane is made by Marion Merrell Dow Inc., a unit of Dow Chemical Co.
